Time to and factors associated with initiation of biological therapy in patients with rheumatoid arthritis in Colombia

Machado‐Alba, Jorge Enrique; García-Betancur, Santiago; Calvo-Torres, L. Felipe; Medina-Morales, Diego Alejandro; Bañol-Giraldo, Alejandra M.

doi:10.1016/j.rcreue.2018.05.003

Cited by 1 publication

(1 citation statement)

References 18 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The prevalence of osteoarticular disease is expected to progressively increase [ 40 ]. In the United States, a 2013 medical cost analysis found that half of all adult medical expenses were for arthritis patients.…”

Section: Discussionmentioning

confidence: 99%

The burden of the most common rheumatic disease in Colombia

et al. 2022

View full text Add to dashboard Cite

Background Estimating the burden of rheumatic diseases (RDs) requires proper evaluation of its lethal and nonlethal consequences. In Colombia, it is possible to find local data and Global Burden of Disease (GBD) reports that collect information from varied contexts and apply complex statistical models, but no on-site estimations are available. Methods This was a descriptive study on the burden of RD based on occurrence and mortality data in the general population during 2015, including information and prevalence estimations from the Community Oriented Program for the Control of Rheumatic Diseases (COPCORD) study. Disability-adjusted life years (DALYs) were estimated by combining measures of years of life lost (YLL) and years lived with disability (YLDs). For disability weight estimations among cases, different COPCORD responses were mapped using flowcharts to show the severity distribution according to GBD. All model parameters and results were validated through an expert consensus panel. Results Low back pain (LBP) was the RD with the greatest burden of disease, costing 606.05 (95% CI 502.76–716.58) DALYs per 100,000 inhabitants, followed by osteoarthritis (292.11; 95% CI 205.76–386.85) and rheumatoid arthritis (192.46, 95% CI 109.7–239.69). Conclusions The burden of RD is as high in Colombia as in other countries of the region. The results offer an interesting tool for optimizing healthcare system design as well as for planning the distribution of human and economic resources to achieve early diagnosis and adequate care of these diseases.

show abstract

Section: Discussionmentioning

confidence: 99%